NARDONE, VALERIO
 Distribuzione geografica
Continente #
NA - Nord America 1.994
EU - Europa 1.820
AS - Asia 365
SA - Sud America 9
OC - Oceania 4
AF - Africa 3
Totale 4.195
Nazione #
US - Stati Uniti d'America 1.987
GB - Regno Unito 652
IE - Irlanda 369
CN - Cina 193
IT - Italia 169
UA - Ucraina 128
SE - Svezia 126
RU - Federazione Russa 122
DE - Germania 84
SG - Singapore 70
FR - Francia 61
FI - Finlandia 38
VN - Vietnam 33
TR - Turchia 31
ES - Italia 25
IN - India 25
BE - Belgio 18
BR - Brasile 9
IM - Isola di Man 7
IR - Iran 7
CA - Canada 6
AU - Australia 4
RO - Romania 4
LT - Lituania 3
NL - Olanda 3
PL - Polonia 3
AT - Austria 2
BD - Bangladesh 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
HK - Hong Kong 2
NO - Norvegia 2
AL - Albania 1
DZ - Algeria 1
GR - Grecia 1
IQ - Iraq 1
PA - Panama 1
PK - Pakistan 1
Totale 4.195
Città #
Southend 610
Dublin 362
Fairfield 279
Chandler 163
Ashburn 140
Ann Arbor 132
Woodbridge 131
Santa Clara 121
Wilmington 117
Jacksonville 108
Seattle 99
Houston 91
Menlo Park 88
Cambridge 81
Siena 69
Singapore 54
Beijing 49
New York 46
Princeton 43
Dong Ket 33
Dearborn 30
Fremont 29
Izmir 28
Nanjing 26
Helsinki 25
Málaga 25
Shanghai 22
Brussels 18
Boardman 16
Florence 14
Munich 12
San Mateo 12
Tianjin 11
Shenyang 10
Nanchang 9
San Diego 9
Moscow 8
Douglas 7
Falls Church 7
Hebei 7
Jiaxing 7
Changsha 6
Kunming 6
Zhengzhou 6
Fort Worth 5
Massa 5
Zanjan 5
Fuzhou 4
Guangzhou 4
Hangzhou 4
Jinan 4
Nuremberg 4
Phoenix 4
Reggio Calabria 4
Sacramento 4
Timisoara 4
Buffalo 3
Espoo 3
Henderson 3
Hounslow 3
Lancaster 3
Mumbai 3
Ningbo 3
Redwood City 3
San Vitaliano 3
Abidjan 2
Bari 2
Bhopal 2
Dallas 2
Delhi 2
Dhaka 2
Duncan 2
Falkenstein 2
Hong Kong 2
Islington 2
Lanzhou 2
London 2
Nardò 2
Oslo 2
Ottawa 2
Prague 2
Priocca 2
Sezze 2
Taizhou 2
Tehran 2
Turin 2
Vienna 2
Vijayawada 2
Wuhan 2
Adelaide 1
Aigaleo 1
Airdrie 1
Amsterdam 1
Araraquara 1
Bangalore 1
Belo Horizonte 1
Borghetto Lodigiano 1
Brainerd 1
Campi Bisenzio 1
Canberra 1
Totale 3.303
Nome #
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 259
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 247
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse 220
3D bone texture analysis as a potential predictor of radiationinduced insufficiency fractures 216
Perilesional edema in brain metastasis from non-small cell lung cancer (NSCLC) as predictor of response to radiosurgery (SRS) 205
Texture analysis as a predictor of radiation-induced xerostomia in head and neck patients undergoing IMRT 189
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 187
Epidermal Growth Factor Receptor Expression predicts Time and Patterns of Recurrence in Glioblastoma Patients Following Radiotherapy and Temozolomide. 164
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 160
Putative role of circulating human papillomavirus DNA in the development of primary squamous cell carcinoma of the middle rectum: a case report 159
Tumor infiltration by T lymphocytes correlates with the outcome of prostate cancer patients treated with salvage radiotherapy 154
The effects of radiotherapy on the survival of patients with unresectable non-small cell lung cancer 153
Texture analysis of parotid gland as a predictive factor of radiation induced xerostomia: A subset analysis 152
Bone structure texture analysis as a potential tool to estimate radiation induced insufficiency fracture risk. 150
null 139
Inflammatory status and lymphocyte of infiltration of primary tumor predict survival of prostate cancer patients undergone prostate radical radiotherapy 138
GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up 137
null 130
Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPP/VAC phase lb program 129
null 126
null 117
null 116
null 82
PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach 75
Bone texture analysis using CT-simulation scans to individuate risk parameters for radiation-induced insufficiency fractures. 64
Combined epidermal growth factor receptor and beclin1 autophagic protein expression analysis identifies different clinical presentations, responses to chemo- and radiotherapy, and prognosis in glioblastoma 63
Prognostic Value of MR Imaging Texture Analysis in Brain Non-Small Cell Lung Cancer Oligo-Metastases Undergoing Stereotactic Irradiation. 60
In Regard to Kubicek et al. 51
The combined EGFR protein expression analysis refines the prognostic value of the MGMT promoter methylation status in glioblastoma. 51
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis 44
CONFIRM trial: what is the real efficacy of second-line immunotherapy in mesothelioma? 43
Persistent hiccup after chemo-radiotherapy in nasopharyngeal cancer: an atypical side effect? 43
Magnetic-resonance-imaging texture analysis predicts early progression in rectal cancer patients undergoing neoadjuvant chemoradiation 37
Is a reduction of radiation dose feasible in patients affected by glioblastoma undergoing radio-chemotherapy according to MGMT promoter methylation status without jeopardizing survival? 27
Role of the Appropriateness of the Pelvic Lymphadenectomy and Adjuvant Radiation Therapy in Early-Stage Poorly Differentiated Endometrial Carcinoma 6
Perilesional edema in brain cancer: Independent prognosticator or epiphenomenon of biomolecular signature? 3
Totale 4.296
Categoria #
all - tutte 13.139
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.139


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020363 0 0 0 0 0 0 0 105 94 83 35 46
2020/2021686 33 77 18 61 54 88 27 84 56 90 24 74
2021/2022400 28 40 30 16 29 25 27 25 29 39 42 70
2022/2023580 28 57 82 70 57 108 19 48 55 32 12 12
2023/2024547 15 9 55 28 16 154 238 3 5 8 2 14
2024/2025402 30 38 120 48 101 41 12 12 0 0 0 0
Totale 4.296